SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 11th, 2019 • Xynomic Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of July 10, 2019, by and between Xynomic Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the Investors set forth on the signature pages affixed hereto (each an “Investor” and collectively the “Investors”).
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Warrant To Purchase Common Stock SharesWarrant Agreement • July 11th, 2019 • Xynomic Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
Xynomic Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, __________________, the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase shares of Common Stock (the “Warrant Shares”) with par value USD$0.0001 each (including any Warrants to purchase shares issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date until the third anniversary of the Issuance Date. Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 17. This Warrant is issued pursuant to that certain Securities Purchase Agreement, dated as of ___________, by and among the
